KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Feb 03, 2026 >>  ABB India 5669.7  [ 3.83% ]  ACC 1670.1  [ 2.09% ]  Ambuja Cements 528.25  [ 3.45% ]  Asian Paints 2426.2  [ 1.04% ]  Axis Bank 1355.55  [ 2.86% ]  Bajaj Auto 9595.5  [ 1.07% ]  Bank of Baroda 285.35  [ 2.77% ]  Bharti Airtel 1997.25  [ 1.61% ]  Bharat Heavy 267.8  [ 3.78% ]  Bharat Petroleum 373.25  [ 1.80% ]  Britannia Industries 5875  [ -0.17% ]  Cipla 1324  [ 0.93% ]  Coal India 430.25  [ 1.68% ]  Colgate Palm 2140.3  [ 0.54% ]  Dabur India 500.45  [ 0.32% ]  DLF 650.2  [ 3.70% ]  Dr. Reddy's Lab. 1235  [ 4.45% ]  GAIL (India) 162.75  [ 1.50% ]  Grasim Industries 2815.15  [ 1.44% ]  HCL Technologies 1690.25  [ 0.84% ]  HDFC Bank 948.4  [ 2.28% ]  Hero MotoCorp 5779.3  [ 2.79% ]  Hindustan Unilever 2371.6  [ 0.67% ]  Hindalco Industries 955.3  [ 2.48% ]  ICICI Bank 1389.3  [ 2.74% ]  Indian Hotels Co. 681.25  [ 2.57% ]  IndusInd Bank 921.95  [ 1.39% ]  Infosys 1654.95  [ 1.59% ]  ITC 316.7  [ 0.60% ]  Jindal Steel 1148.4  [ 2.13% ]  Kotak Mahindra Bank 416  [ 1.91% ]  L&T 4037.65  [ 2.95% ]  Lupin 2187.15  [ 2.75% ]  Mahi. & Mahi 3527.9  [ 1.87% ]  Maruti Suzuki India 14779.6  [ 2.73% ]  MTNL 31.96  [ 2.57% ]  Nestle India 1309.15  [ 0.12% ]  NIIT 78.15  [ 1.92% ]  NMDC 81.62  [ 0.02% ]  NTPC 358.55  [ 2.33% ]  ONGC 257.1  [ 1.22% ]  Punj. NationlBak 123.85  [ 1.47% ]  Power Grid Corpo 283.25  [ 4.85% ]  Reliance Industries 1437.85  [ 3.43% ]  SBI 1064.25  [ 3.48% ]  Vedanta 675.6  [ 2.21% ]  Shipping Corpn. 221.55  [ 2.40% ]  Sun Pharmaceutical 1702.8  [ 4.54% ]  Tata Chemicals 727.35  [ 0.17% ]  Tata Consumer Produc 1150  [ 2.19% ]  Tata Motors Passenge 372  [ 2.51% ]  Tata Steel 192.95  [ 2.31% ]  Tata Power Co. 365.05  [ 1.76% ]  Tata Consult. Serv. 3223.7  [ 1.72% ]  Tech Mahindra 1714  [ -0.57% ]  UltraTech Cement 12581.05  [ 0.39% ]  United Spirits 1366.5  [ 1.53% ]  Wipro 242.45  [ 0.10% ]  Zee Entertainment En 82.73  [ 1.70% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

03 February 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 203.04 Face Value 10.00
Bookclosure 19/09/2025 52Week High 561 EPS 5.24 P/E 70.31
Market Cap. 499.72 Cr. 52Week Low 293 P/BV / Div Yield (%) 1.81 / 0.27 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh. MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales. MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively. 2010 -The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share) -The Company appointed Mr. B.K.Gupta as Managing Director. 2011 -The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan. 2013 -Ms. Harshita Sharma has been appointed as Additional Director of the company. 2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd. 2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant. 2020 -Global API Facility started Dahej API Plant. 2021 -Operations started Haridwar formulation Unit II(FDF). 2023 -Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024
-Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece.
-Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.